Introducing our new and improved Hot Tort Report
Being industry experts, we pride ourselves on keeping our finger on the pulse of all things Multi District Litigation. This predominantly consists of providing our subscribers with competitive insights into where the money is being spent in hopes of informing your blueprint for advertising strategies. These cases can be highly lucrative, but are difficult to acquire, requiring significant investment and patience to secure high-value cases.
We’ve been working hard on an algorithm to deliver more than just monthly TV spends and are proud to announce that we are ready to unveil our HTR 2.0.
This new list offers an overview of dollars spent across TV, Meta, PPC, and more, assigning a score to each tort based on what we, as leaders in the law firm advertising space, are witnessing across these various platforms.
The Hot Tort Report:
May 2025
The Hottest in Mass Tort Spending: April 2025
Birth Control Injections
Featured Tort
Subscribe to the Hot Tort Report
What’s the Tort News?
Published: May, 2025. Advertising spend from multiple sources for a recent 30 day period.
If you have any questions, please contact Bails at bails@whitehardt.com
#1 Roundup®
Roundup® climbed decisively to the top this month, gaining significant momentum across channels. Performance is up sharply since March, driven by a strong surge in Meta interest and a boost in WHii. TV and PPC activity remain fully loaded.
Bayer’s recent petition to the U.S. Supreme Court in the Durnell case aims to overturn a California appeals court decision, arguing that EPA-approved labeling should preempt state-level failure-to-warn claims. It’s a bold legal move, and we will continue to update as it plays out.
CPA: $5,935
CPL: $3,561
For criteria, please contact us.
#2 Birth Control Injections
The Birth Control Injections mass tort cooled down some this month, with a notable drop in overall performance compared to March. WHii is trending upward, but declines in Meta, TV, and PPC have pulled the total score down.
A recent court order approving the collection of medical and pharmacy records signals continued progress and potential for renewed activity. If your firm is looking to engage with this featured tort, we are here to help you strategize.
CPA: $1,280 – $5,454
CPL: $640 – $2,727
For criteria, please contact us.
#3 Ultra-Processed Foods
The Ultra-Processed Foods tort is showing early signs of traction. Meta is the strongest channel so far, while WHii, TV, and PPC remain in the early stages. The FDA’s move to phase out artificial dyes, and speculation about this tort becoming “the next tobacco” have started to fuel broader awareness. While still in its infancy, we expect this tort to continue bringing the heat.
CPA: $8,794
CPL: $4,397
For criteria, please contact us.
#4 Paraquat
The Paraquat mass tort saw a drop in overall performance this month, led by a sharp decline in WHii and a slight dip in TV activity.
Meta engagement is on the rise, likely fueled by headlines confirming that the manufacturer has agreed to settle a large portion of the more than 5,800 active claims in federal multidistrict litigation. While the settlement won’t resolve all cases, it signals a turning point in the ongoing legal battle over paraquat’s alleged link to Parkinson’s disease.
CPA: $2,729
CPL: $1,165
Common Criteria: Diagnosis of Parkinson’s Disease or experiencing Parkinson’s-like symptoms after exposure to Paraquat.
#5 Video Game Addiction
The Video Game Addiction mass tort saw a slight dip this month. WHii and Meta are up modestly, but decreases in TV and PPC keep overall movement flat. Still, this tort is in the early stages, and we are working with law firms to help connect them with the families of video-game-addicted children.
CPA: $367
CPL: $165
Common Criteria: Child must be under 18 and spend 4+ hours per day, 5+ days per week, playing Minecraft, Fortnite, GTA 5, or Call of Duty. The child must also experience one or more of the following: addiction, poor school performance, school dropout, cognitive or developmental delays, chronic depression or anxiety, or self-harm/suicidal behavior.
#7 Takata Airbag Recall
The Takata Airbag Recall mass tort showed modest growth this month, with slight increases in both Meta and TV activity, the former rebounding from zero activity in March. WHii remains inactive, but the upward movement across consumer-facing channels suggests a possible resurgence.
For metrics such as CPA, CPL, and common criteria, please contact us.
#8 Talcum Powder
A recent setback for Johnson & Johnson, with its third bankruptcy attempt rejected, adds new legal uncertainty to this already long-running litigation. While PPC maintains a maximum score, engagement on the other platforms is still limited.
CPA: $940
CPL: $470
For criteria, please contact us.
#9 Birth Injury
The Birth Injury mass tort moved up into the top ten this month, doubling its score thanks to a sharp increase in both TV and Meta activity. WHii remains inactive, but the rise in consumer-facing channels suggests growing public attention.
For metrics such as CPA, CPL, and common criteria, please contact us.
#10 AFFF
The AFFF mass tort saw a slight overall gain this month. WHii and Meta showed modest improvement, while TV has shown no movement. PPC continues to hold steady, keeping this tort in the top ten.
CPA: $3,500
CPL: $1,750
For criteria, please contact us.
Mesothelioma
You may be noticing a tort missing from our new report. While Mesothelioma continues to dominate the competition when it comes to spend levels, Whitehardt finds that this tort is its own niche animal. These cases can be extremely fruitful, but hard to come by, requiring a high buy-in to get in the game and patience when landing that ringer of a case. We believe that Meso will remain a constant for some time, but in regards to many of the other drugs and devices we focus on in this monthly report, we’ve decided to move it to its own category. If you are interested in hearing the latest news on Meso or how Whitehardt may be currently seeking these cases, you can contact us here.
Whitehardt will continue to track meso spending from month to month, so if you are interested in ongoing meso spending, please reach out to me directly. Going forward, we will be excluding meso from these tort reports.
